TransMedics Group, Inc. — Director's Dealing 2024

Jan 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2024-01-16

Reporting Person: Khayal Tamer I (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-16	Common Stock	M	10000	$13.28	Acquired	24375	Direct
2024-01-16	Common Stock	S	9867	$80.40	Disposed	14508	Direct
2024-01-16	Common Stock	S	133	$81.06	Disposed	14375	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-16	Stock Option (Right to Buy)	$13.28	M	10000	Disposed	2032-02-22	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14776	Indirect
Common Stock	11051	Indirect

Footnotes

F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $81.045 to $81.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.